人乙酰肝素酶以稳定形式定位于溶酶体内。

Human heparanase is localized within lysosomes in a stable form.

作者信息

Goldshmidt Orit, Nadav Liat, Aingorn Helena, Irit Cohen, Feinstein Naomi, Ilan Neta, Zamir Eli, Geiger Benjamin, Vlodavsky Israel, Katz Ben Zion

机构信息

Vascular Biology Research Center, the Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.

出版信息

Exp Cell Res. 2002 Nov 15;281(1):50-62. doi: 10.1006/excr.2002.5651.

Abstract

Heparanase is an endo-beta-D-glucuronidase involved in degradation of heparan sulfate (HS) and extracellular matrix (ECM) of a wide range of cells of vertebrate and invertebrate tissues. The enzymatic activity of heparanase is characterized by specific intrachain cleavage of glycosidic bonds with a hydrolase mechanism. This enzyme facilitates cell invasion and hence plays a role in tumor metastasis, angiogenesis, inflammation, and autoimmunity. Although the expression pattern and molecular properties of heparanase have been characterized, its subcellular localization has not been unequivocally determined. We have previously suggested that heparanase subcellular localization is a major determinant in regulating the enzyme's biological functions. In the present study we examined heparanase localization in three different cell types, utilizing immunofluorescent staining and electron microscopy. Our results indicate that heparanase is localized primarily within lysosomes and the Golgi apparatus. A construct composed of heparanase cDNA fused to green fluorescent protein, utilized in order to visualize the enzyme within living cells, confirmed its localization in acidic vesicles. We suggest that following synthesis, heparanase is transported into the Golgi apparatus and subsequently accumulates in a stable form within the lysosomes, where it functions in HS turnover. The lysosomal compartment may also serve as a site for heparanase confinement within the cells, limiting its secretion and uncontrolled extracellular activities associated with tumor metastasis and angiogenesis.

摘要

乙酰肝素酶是一种内切-β-D-葡糖醛酸酶,参与降解脊椎动物和无脊椎动物组织中多种细胞的硫酸乙酰肝素(HS)和细胞外基质(ECM)。乙酰肝素酶的酶活性以糖苷键的特异性链内切割为特征,其作用机制为水解酶机制。该酶促进细胞侵袭,因此在肿瘤转移、血管生成、炎症和自身免疫中发挥作用。尽管乙酰肝素酶的表达模式和分子特性已得到表征,但其亚细胞定位尚未明确确定。我们之前曾提出,乙酰肝素酶的亚细胞定位是调节该酶生物学功能的主要决定因素。在本研究中,我们利用免疫荧光染色和电子显微镜检查了三种不同细胞类型中乙酰肝素酶的定位。我们的结果表明,乙酰肝素酶主要定位于溶酶体和高尔基体中。为了在活细胞中可视化该酶,构建了一个由乙酰肝素酶cDNA与绿色荧光蛋白融合而成的构建体,该构建体证实了其在酸性囊泡中的定位。我们认为,合成后,乙酰肝素酶被转运至高尔基体,随后以稳定形式在溶酶体中积累,在溶酶体中它参与HS的周转。溶酶体区室也可能是细胞内限制乙酰肝素酶的位点,限制其分泌以及与肿瘤转移和血管生成相关的不受控制的细胞外活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索